Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Bioinformatics Analysis Revealed Immune Checkpoint Genes Relevant to Type 2 Diabetes. | Diabetes Metab Syndr Obes | 2024 | 38881696 | PubTator, text mining | PubMed |
| Chemotherapy resistance in acute myeloid leukemia is associated with decreased anti-tumor immune response through MHC molecule and B7 family members. | Discov Oncol | 2024 | 38861194 | PubTator, text mining | PubMed |
| Aberrant expression of B7-H4 and B7-H5 contributes to the development of cutaneous squamous cell carcinoma. | Arch Dermatol Res | 2024 | 38850312 | PubTator, text mining | PubMed |
| Editorial: Developmental biology and endocrine research for a successful pregnancy. | Front Endocrinol (Lausanne) | 2024 | 38803471 | PubTator, text mining | PubMed |
| B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas. | Neoplasia | 2024 | 38796932 | PubTator, text mining | PubMed |
| Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics. | J Ovarian Res | 2024 | 38778371 | PubTator, text mining | PubMed |
| NKX2‑1 copy number alterations are associated with oncogenic, immunological and prognostic remodeling in non‑small cell lung cancer. | Oncol Lett | 2024 | 38774453 | PubTator, text mining | PubMed |
| Prognostic Value of B7H4 Expression in Patients with Solid Cancers: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2024 | 38732263 | PubTator, text mining | PubMed |
| Is it possible to identify COVID-19 infection-related biomarkers during pregnancy?: A prospective study in Turkish population. | Medicine (Baltimore) | 2024 | 38728492 | PubTator, text mining | PubMed |
| Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer. | Cancer Res Commun | 2024 | 38687247 | PubTator, text mining | PubMed |
| Clinical relevance of glycosylation in triple negative breast cancer: a review. | Glycoconj J | 2024 | 38634956 | PubTator, text mining | PubMed |
| Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma. | JCO Precis Oncol | 2024 | 38547421 | PubTator, text mining | PubMed |
| [Preparation and characterization of chicken anti-human B7-H4 IgY polyclonal antibody]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2024 | 38512036 | PubTator, text mining | PubMed |
| Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells. | Sci Rep | 2024 | 38480774 | PubTator, text mining | PubMed |
| Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma. | World J Clin Oncol | 2024 | 38455128 | PubTator, text mining | PubMed |
| Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells. | BMC Nutr | 2024 | 38439112 | PubTator, text mining | PubMed |
| Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial carcinoma of bladder as a potential therapeutic target. | Med Oncol | 2024 | 38376603 | PubTator, text mining | PubMed |
| DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications. | Eur J Med Res | 2024 | 38326910 | PubTator, text mining | PubMed |
| Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects. | PLoS One | 2024 | 38306344 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates: Advancing from Magic Bullet to Biological Missile. | Clin Cancer Res | 2024 | 38306232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=9